Close Menu

NEW YORK – Clinicians, scientists, and other members of the cancer care and research community gathered in San Francisco for the American Society of Clinical Oncology's Gastrointestinal Cancers Symposium from Jan. 23 to 25. The meeting featured an array of presentations on the research advances being made in treating cancers of the esophagus, stomach, pancreas, small bowel and hepatobiliary tract, and the colon, rectum, and anus. Here is a roundup of the abstracts that highlighted a precision cancer approach in either diagnosis or treatment.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Apr
27
Sponsored by
Biognosys

This webinar, the first in our Next-Generation Proteomics for Precision Oncology series, will discuss how proteomics can help overcome the challenges of treating COVID-19 patients with oncologic comorbidities.

Jun
16
Sponsored by
Biognosys

This webinar, the second in our Next-Generation Proteomics for Precision Oncology series, will discuss how unbiased discovery proteomics can be used to identify new key mechanisms and signatures supporting clinical decision-making for melanoma patients.

Jun
18
Sponsored by
Canexia Health

Last year, by Precision Oncology News' count, the FDA approved 27 precision oncology drugs, a 35 percent increase in the number of approvals from 2019.